Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention
Open Access
- 1 January 2010
- journal article
- Published by Springer Science and Business Media LLC in Behavioral and Brain Functions
- Vol. 6 (1), 32
- https://doi.org/10.1186/1744-9081-6-32
Abstract
In contrast to studies of depression and psychosis, the first part of this study showed no major differences in serum levels of cytokines and tryptophan metabolites between healthy children and those with attention-deficit/hyperactivity disorder of the combined type (ADHD). Yet, small decreases of potentially toxic kynurenine metabolites and increases of cytokines were evident in subgroups. Therefore we examined predictions of biochemical associations with the major symptom clusters, measures of attention and response variability. We explored systematically associations of 8 cytokines (indicators of pro/anti-inflammatory function) and 5 tryptophan metabolites with symptom ratings (e.g. anxiety, opposition, inattention) and continuous performance test (CPT) measures (e.g. movement, response time (RT), variability) in 35 ADHD (14 on medication) and 21 control children. Predictions from linear regressions (controlled by the false discovery rate) confirmed or disconfirmed partial correlations accounting for age, body mass and socio-economic status. (1) Total symptom ratings were associated with increases of the interleukins IL-16 and IL-13, where relations of IL-16 (along with decreased S100B) with hyperactivity, and IL-13 with inattention were notable. Opposition ratings were predicted by increased IL-2 in ADHD and IL-6 in control children. (2) In the CPT, IL-16 related to motor measures and errors of commission, while IL-13 was associated with errors of omission. Increased RT variability related to lower TNF-alpha, but to higher IFN-gamma levels. (3) Tryptophan metabolites were not significantly related to symptoms. But increased tryptophan predicted errors of omission, its breakdown predicted errors of commission and kynurenine levels related to faster RTs. Many associations were found across diagnostic groups even though they were more marked in one group. This confirms the quantitative trait nature of these features. Conceptually the relationships of the pro- and antiinflammatory cytokines distinguished between behaviours associated more with cognitive or more with motor control respectively. Further study should extend the number of immunological and metabolic markers to confirm or refute the trends reported here and examine their stability from childhood to adolescence in a longitudinal design.Keywords
This publication has 70 references indexed in Scilit:
- Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medicationBehavioral and Brain Functions, 2010
- Gender, race/ethnicity, personality, and interleukin-6 in urban primary care patientsBrain, Behavior, and Immunity, 2009
- Clinical and molecular-genetic markers of ADHD in children.2008
- Dopamine–serotonin interactions in attention-deficit hyperactivity disorder (ADHD)Progress in Brain Research, 2008
- Kynurenine pathway in major depression: Evidence of impaired neuroprotectionJournal of Affective Disorders, 2007
- Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?Journal of Neural Transmission, 2006
- Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing ratsJournal of Neurochemistry, 2006
- Kynurenic acid has a dual action on AMPA receptor responsesNeuroscience Letters, 2006
- Tumor Necrosis Factor-α–Induced Synthesis of Interleukin-16 in Airway Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypesNature Reviews Neuroscience, 2002